Detalhe da pesquisa
1.
Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3.
Immunity
; 55(8): 1501-1514.e3, 2022 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35777362
2.
Structural basis and analysis of hamster ACE2 binding to different SARS-CoV-2 spike RBDs.
J Virol
; 98(3): e0115723, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38305152
3.
Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants.
J Virol
; 96(17): e0081422, 2022 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-36000849
4.
Exploration in the Mechanism of Ginsenoside Rg5 for the Treatment of Osteosarcoma by Network Pharmacology and Molecular Docking.
Orthop Surg
; 16(2): 462-470, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38086608
5.
Rapid evaluation of heterologous chimeric RBD-dimer mRNA vaccine for currently-epidemic Omicron sub-variants as booster shot after inactivated vaccine.
Biosaf Health
; 5(2): 89-100, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37123450
6.
Two pan-SARS-CoV-2 nanobodies and their multivalent derivatives effectively prevent Omicron infections in mice.
Cell Rep Med
; 4(2): 100918, 2023 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36702124
7.
Molecular insights into receptor binding of recent emerging SARS-CoV-2 variants.
Nat Commun
; 12(1): 6103, 2021 10 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34671049